Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

An International, Phase III, Randomized Trial of Mycophenolate Mofetil in Myasthenia Gravis
Neurol 71:400-406, 390, Sanders,D.B.,et al., 2008
See this aricle in Pubmed

Article Abstract
Initiation of mycophenolate mofetil (MMF) treatment was not superior to placebo in maintaining myasthenia gravis (MG) control during a 36-week schedule of prednisone tapering. There were no significant differences in the primary or secondary endpoints between the study groups. MMF was well tolerated and adverse events were consistent with previous studies. Experience from this large, international, multicenter, phase III study employing full MG Foundation of America guidelines will aid the design of future MG studies.
 
Related Tags
(click to filter results - removes previous filter)

complications
efficacy
myasthenia gravis
myasthenia gravis,treatment of
mycophenolate
safety
steroid
steroid therapy,CNS treatment and complications with
treatment of neurologic disorder

Click Here to return To Results